跳至主要内容
临床试验/NCT05180136
NCT05180136已完成不适用

Efficacy and Tolerability of Rice Bran Extract in Mildly to Moderately Depressed Patients: a Double-blind, Randomized, Placebo-controlled Study

Pusan National University Yangsan Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年1月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
The Korean version of the Hamilton Depression Rating Scale (K-HDRS)

研究概览

简要总结

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects and tolerability of rice bran extract on depressive symptoms and related biomarkers in mildly to moderately depressed patients for 8 weeks.

详细描述

A previous animal study has indicated that rice bran extract provided inhibition of MAO-B enzyme activity and ROS formation in a corticosterone-induced depression-like animal model. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of rice bran extract on depressive symptoms and related biomarkers in mildly to moderately depressed patients for 8 weeks; the safety of the compound is also evaluated. The Investigators examine the Korean version of the Hamilton Depression Rating Scale, the Korean Version of the Beck-II Depression Inventory, the Korean version of the Patient Health Questionnaire-9, the Perceived Stress Scale, the Korean version of the Beck Anxiety Inventory and biomarkers at baseline and after 8 weeks of intervention. One hundred adults were administered either 1,000 mg of rice bran extract or a placebo each day for 8 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
19 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •- the Korean version of the Hamilton Depression Rating Scale score between 7-24

排除标准

  • •No depressive symptom (K-HRSD ≤ 6) or severely depressed (K-HRSD ≥ 25)
  • •Those are taking hormone therapy such as estrogen within the past 6 months
  • •Those are taking the following drugs within the last 1 month or need to take them during the study period (sleep aids, antidepressants, selective estrogen receptor modulators, etc.)
  • •Those with a history of treatment for depression
  • •Abnormal liver or renal function (more than twice the normal upper limit of the research institute)
  • •Uncontrolled diabetes mellitus (>160 mg/dL of fasting blood sugar)
  • •Uncontrolled hypertension (>160/100 mmHg)
  • •Uncontrolled thyroid diseases.
  • •Those who are taking drugs, functional foods, herbs, etc. that may affect depression
  • •Alcohol abuser
  • •Allergic reaction to this test food
  • •Those who participated in other drug clinical trials within 1 month from the screening date.
  • •Severe gastrointestinal symptoms such as heartburn and indigestion
  • •Those who are pregnant, lactating, or plan to become pregnant during the clinical trial
  • •Those who are judged to be unsuitable by the PI for other reasons

研究组 & 干预措施

Rice bran extract group

Experimental

This group takes rice bran extract for 8 weeks.

干预措施: Rice bran extract group (Dietary Supplement)

Control group

Placebo Comparator

This group takes a placebo for 8 weeks.

干预措施: Control group (Dietary Supplement)

结局指标

主要结局

The Korean version of the Hamilton Depression Rating Scale (K-HDRS)

时间窗: 8 weeks

using K-HDRS score. The minimum score was 0 and the maximum score was 50, and higher scores mean a worse outcome.

次要结局

  • The Korean version of the Beck Anxiety Inventory (K-BAI)(8 weeks)
  • salivary cortisol concentration (U/mL)(8 weeks)
  • The Korean Version of the Beck-II Depression Inventory (K-BDI II)(8 weeks)
  • The Korean of the Perceived Stress Scale(K-PSS)(8 weeks)
  • serotonin concentration (nM)(8 weeks)
  • The Korean version of the Patient Health Questionnaire-9 (K-PHQ-9)(8 weeks)
  • Brain-derived neurotrophic factor concentration (ng/ml)(8 weeks)
  • dopamine concentration (pg/μL)(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sang Yeoup Lee

Professor

Pusan National University Yangsan Hospital

研究点 (1)

Loading locations...

相似试验